| Literature DB >> 17273943 |
Gary D Kruh1, Martin G Belinsky, James M Gallo, Kun Lee.
Abstract
The MRP family is composed of nine transporters, at least eight of which are lipophilic anion transporters that are capable of conferring resistance to various anticancer agents. Recently, mice with gene disruptions in Mrp2, Mrp3 and Mrp4 have been developed. This review will discuss insights into the physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 afforded by investigations of these new mouse models.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17273943 DOI: 10.1007/s10555-007-9039-1
Source DB: PubMed Journal: Cancer Metastasis Rev ISSN: 0167-7659 Impact factor: 9.264